| Literature DB >> 35278306 |
Kathleen M E Gallagher1,2,3, Mark B Leick2,4, Rebecca C Larson2,4, Trisha R Berger2, Katelin Katsis1,2, Jennifer Y Yam1,2, Marcela V Maus2,4.
Abstract
COVID-19 breakthrough cases among vaccinated individuals demonstrate the value of measuring long-term immunity to SARS-CoV-2 and its variants. We demonstrate that anti-spike T-cell responses and IgG antibody levels are maintained but decrease over time and are lower in BNT162b2- versus mRNA-1273-vaccinated individuals. T-cell responses to the variants are relatively unaffected.Entities:
Keywords: BNT162b2; SARS-CoV2 mRNA vaccine; T-cell immunity; T-cell response; mRNA-1273
Mesh:
Substances:
Year: 2022 PMID: 35278306 PMCID: PMC9402689 DOI: 10.1093/cid/ciac201
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 20.999